Description

Specifications

Specification
242*267*108mm
3kg
220V 50hz, 60W

Interface
7-inch Touch-screen
RS232, Network RJ45 and Multiple USB
Build-in 57nm thermal printer

Multi Parameters Test
Both Quantitative Qualitative
Instant Test, Auto Test, and Sequence Test
100,000 Result

Cardiac
cat#.	Product item	Specimen	Reaction Time	Measure Range	Clinical Range	Itended Use
1	cTnI	WB/Serum/Plasma	12min.	0.1-40ng/ml	<0.3ng/ml	several heart diseases including myocardial infarction and heart failure.
2	Myo	WB/Serum/Plasma	12min.	5-400ng/ml	<58ng/ml	acute myocardial infarction (AMI) in early stage.
3	CK-MB	WB/Serum/Plasma	12min.	1-200ng/ml	<5ng/ml	acute myocardial infarction (AMI) in early stage.
4	NT-proBNP	WB/Serum/Plasma	10min.	20-35000pg/ml	Under 75：0~347pg/mL， Over 75：0~449pg/mL	heart failure .
5	D-Dimer	WB/Plasma	10min.	40-10000ng/ml	<500ng/ml	disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
7	ST2	WB/Serum/Plasma	10min.	10-400ng/ml	<35ng/ml	heart failure .
Inflammation
11	CRP / hs-CRP	WB/Serum/Plasma	3min.	0.5-200mg/L	CRP<10mg/L，hs-CRP<1mg/L	nonspecficity inflammatory marker.
12	SAA	WB/Serum	5min.	1-200mg/L	<10mg/L	inflammation&infection.
13	PCT	WB/Serum/Plasma	10min.	0.2-100ng/ml	<0.5ng/ml	Sepsis
15	IL-6	WB/Serum/Plasma	10min.	5-4000pg/ml	10pg/ml	diabetes,rheumatoid arthritis,etc
Thyroid Hormone
17	TSH	WB/Serum/Plasma	15min.	0.3-100mU/L	0.3-4.2mU/L	hyperthyroidism and hypothyroidism
18	TT3	WB/Serum/Plasma	15min.	0.5-10nmol/L	1.23-3.07nmol/L	thyroid dysfunction
19	TT4	WB/Serum/Plasma	15min.	5-300nmol/L	66-181nmol/L	thyroid dysfunction
20	FT3	WB/Serum/Plasma	15min.	1-50pmol/L	3.1-6.8pmol/L	thyroid dysfunction
21	FT4	WB/Serum/Plasma	15min.	5-100pmol/L	12-22pmol/L	thyroid dysfunction
Tumor Maker
22	AFP	WB/Serum/Plasma	10min.	2.5-200ng/ml	<20ng/ml	pregnancy cancer
23	CEA	WB/Serum/Plasma	10min.	1-200ng/ml	<5ng/ml	colon cancer, colorectal cancer,etc.
26	PG II	WB/Serum/Plasma	10min.	1-100ug/L	PGI/PGII>3.0	gastric abnormalities
27	PG I	WB/Serum/Plasma	10min.	2.5-200ug/L	>70ng/ml	gastric abnormalities
28	TPSA	WB/Serum/Plasma	10min.	0.5-40ng/ml	<4ng/ml	prostate cancer
29	FPSA	WB/Serum/Plasma	10min.	0.1-10ng/ml	<1ng/ml	prostate cancer
30	CA12-5	WB/Serum/Plasma	10min.	20-500U/ml	<35U/ml	ovarian cancer
31	CA15-3	WB/Serum/Plasma	10min.	10-400U/ml	< 25 U/mL	breast cancer
33	CA19-9	WB/Serum/Plasma	10min.	10-400U/ml	< 27 U/mL	pancreatic cancer
Fertility
36	β-HCG	WB/Serum/Plasma	10min.	2-100000mIU/ml	<5 mIU/mL	early pregrancy.
37	AMH	WB/Serum/Plasma	10min.	0.1-16ng/ml	Male: 20-60 years old, 0.92-13.89 ng/mL Female: 20-29 years old, 0.88-10.35 ng/mL 30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL	ovarian reserve level
38	LH	WB/Serum/Plasma	15min.	1-100mIU/ml	Male: 1.81-8.16 mIU/mL; Female: Follicular phase : 2.95 -13.65 mIU/mL Ovulation phase: 13.65-95.75 Miu/mL Luteal phase: 1.25-11.00 mIU/mL Menopause phase: 8.74 -55.00 mIU/mL	reproductive dysfunction
39	FSH	WB/Serum/Plasma	15min.	1-100mIU/ml	Male: 1.50-12.40 mIU/mL Female: Follicular phase : 4.46-12.43 mIU/mL Ovulation phase: 4.88-20.96 mIU/mL Luteal phase: 1 .95-8.04 mIU/mL Menopause phase: 20.00-98.62 mIU/mL	reproductive system
40	Testosterone	WB/Serum/Plasma	15min.	0.2-15ng/ml	Male: 20-49 years old, 1.91-8.41 ng/mL >50 years old, 1.61-8.01 ng/mL Female: 20-49 years old,<0.80ng/mL >50 years old, <0.71 ng/mL	sexual hormone disturbance and hypogonadism.
41	Progesterone	WB/Serum/Plasma	15min.	1.4-60ng/ml	Male: 0-1.5ng/mL Female: Follicular phase : 0-1.9ng/mL Ovulation phase: 0-12ng/mL Luteal phase: 1.7-28.7ng/mL Menopause phase:0-1.4ng/mL Pregnancy:11-60ng/mL	pregrancy progesterone
42	PRL	WB/Serum/Plasma	15min.	1-200ng/ml	Male: 3.45-17.42 ng/mL Female (non-pregnant): 4.60-25.07 ng/mL	breastfeeding&abnormal lactation
44	E2	WB/Serum/Plasma	15min.	9-3000pg/ml	Male: <85 pg/mL Female: Follicular Phase: 12-262 pg/mL Ovulation: 40-396 pg/mL Luteal Phase: 21-381 pg/mL Menopause: <190 pg/mL Pregnancy: >145 pg/mL	ovarian vitality.
Gastrointestinal
47	FOB+TRF	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
Infection
48	Covid-19 Antigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
49	Covid-19 Ab IgG/IgM	WB/Serum/Plasma	15min.	qualitative	qualitative	respiratory tract
50	FluA Antigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
51	FluB Antigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
52	HPAntigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	0.05-100ng/mL	<0.1ng/mL	pylori infection
53	HP IgG	WB/Serum/Plasma	15min.	3-80ng/mL	<5ng/mL	pylori infection
Renal injury
54	CysC	WB/Serum/Plasma	5min.	0.4-9mg/L	0.5-1.1mg/L	renal function
55	NGAL	Urine	10min.	10-1500ng/mL	<132ng/mL	acute kidney injury.
56	MAU	Urine	10min.	5-300mg/l	<20mg/l	renal function.
Diabetes
59	HbA1c	WB	10min.	4%-14%	4%-6%	diabetes
60	Insulin	WB/Serum/Plasma	15min.	1 – 200 µU/mL	5-20µU/mL	diabetes
61	C-peptide	WB/Serum/Plasma	15min.	0.1 - 16ng/mL	0.33-3.76ng/mL	diabetes
Brain diseases
62	S100β	WB/Serum/Plasma	10min.	0.05-10ng/ml	<0.2ng/ml	Cerebral infarction, cerebral injury.
Nutritional metabolism
63	FERR	WB/Serum/Plasma	5min.	10-500ng/mL	Male:24ng/mL~335ng/mL, Female:11ng/mL~307ng/mL	iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
64	VD	WB/Serum/Plasma	15min.	30-120ng/mL	30-70ng/mL	osteoporosis
65	VB12	WB/Serum/Plasma	15min.	50-2000pg/mL	200-900pg/mL	VB12 deficiency
Autoimmune
66	Total IgE	WB/Serum/Plasma	10min.	0.05-10mg/L	0.1-0.9mg/L	allergy, rickets
Rheumatoid
67	Anti-CCP	WB/Serum/Plasma	15min	7-300U/mL	≤ 7 U/mL	Rheumatoid Arthritis
68	RF	WB/Serum/Plasma	15min	3-120IU/mL	≤ 3IU/mL	Rheumatoid Arthritis
69	ASO	WB/Serum/Plasma	15min	100-1000IU/Ml	≤ 100IU/mL	Rheumatoid Arthritis